Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum91279Research ArticleTsefalosporiny IV pokoleniya v lechenii tyazhelykh infektsiy u deteyBeloborodovaN. V-150420002416617028122021Copyright © 2000, Consilium Medicum2000[Яковлев С.В. Цефепим - цефалоспориновый антибиотик 4-го поколения; Антибиотики и химиотерапия, 1999; 44(7): 32-7.][Vostricova T.Yu, Beloborodova N.V., Kurchavov V.A. In vitro activity of Cefepime and other antimicrobials against gram - negative bacteria. J Chemother April 1999; 11(suppl.2): 107.][Quadri S.M., Cunha B.A., Ueno Y., Abumustafa E., et al: Activity of cefepime against nosocomical blood culture isolates; J Antimicrob Chemother 1995 Sep; 36(3): 531-6.][Sofianou D., Tsoufla S., Kontodmou L., Polydorou F., Malaka E.: Comparative in vitro activity of cefepime against nosocomical isolates. J. Chemother, Oct 1997; 9(5): 341-6.][Mebis J., Goossens H., Bruyneel P. et al. Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients. Leukemia, 1998; 12: 1627-9.][Hancock R.E, Bellido F. Antibacterial in vitro activicy of fourth generation cephalosporins. J.Chemoherapy 1996; 8(Suppl.2): 31-6.][Ramphal R., Gulcap R., Rotstain C. et al. Clinical expirience with single agent and combination regimens in the management of infection in the febrile neutropenic patient. Am.J.Med., 1996; 100: 83-9.][Saez-Llorens X.,Castano E., Garcia R., Baez C., Perez M., Tejeira F., Mc Cracken G.H.Jr.: Prospective Randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children; Antimicrob Agents Chemother Apr. 1995; 39(4): 937-40.][Reed M.D., Yamashita T.S., Knupp C.K., Veazey J.M.Jr, Blumer J.L: Pharmacokinetics of intravenously and intramascularly administered cefepime in infants and children; Antimicrob Agents Chemother Aug 1997; 41(8): 1783-7.][Schaad U.B., Eskola J., Kafetzis D, Fishbach M., Ashkenazi S., Syriopoulou V., Boulesteix J., De Pril V., Gres J.J, Rollin C.: Cefepime vs. Ceftazidime treatment of pyelonephritis: a European, randomized, controlle study of 300 pediatric cases. European Society for Paediatric Infectious Disease (ESPID) Pyelonephritis Study Group; Paediatr Infect Dis J Jul 1998; 17(7): 639-44.][Mustafa M.M. Cefepime versus Ceftazidime in the Empiric Treatment of Febrile Neutropenic Children with Malignancy. In: Febrile Neutropenia /J.A.Klastersky (ed.), 1997; 75-6.][Neu H.C.:Safety of cefepime: a new extended - spectrum parenteral cephalosporin; Am J Med Jun 1996; 24; 100(6A): 68S-75S.]